Diagnosis of Hodgkin’s disease, Hodgkin’s-like anaplastic large cell lymphoma, and T cell/histiocyte-rich B cell lymphoma

  • H. Stein


Although Hodgkin’s disease is relatively well defined, there are borderline cases in which this disease overlaps with non-Hodgkin’s lymphoma. Fortunately, there are only two such areas: lymphocyte predominance Hodgkin’s disease (LPHD) versus T-cell-rich B cell lymphoma (TCRBCL); and classical Hodgkin’s disease versus anaplastic large cell lymphoma (ALCL) [52.1]. Before dealing with these overlaps in detail, we should consider why it is necessary to be concerned about the distinction between these diseases. The answer lies in their different clinical behavior. TCRBCL is an aggressive disorder — as reflected in the fact that patients suffering from this disease are usually at Stage III and IV — whereas LPHD is indolent, and usually presents at Stage I or II. Bone marrow involvement is frequent in TCRBCL but rarely in LPHD.


Borderline Case Bone Marrow Involvement Follicular Dendritic Cell International Lymphoma Study Group Aggressive Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Harris NL Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–92.Google Scholar
  2. 2.
    Orscheschek K, Merz H, Hell J, Binder T, Bartels H, Feller AC. Large-cell anaplastic lymphoma-specific translocation (t[2; 5] [p23; q35]) in Hodgkin’s disease: indication of a common pathogenesis? Lancet 1995; 345: 87–90.PubMedCrossRefGoogle Scholar
  3. 3.
    Herbst H, Anagnostopoulos J, Heinze B, Durkop H, Hummel M, Stein H. ALK gene products in anaplastic large cell lymphomas and Hodgkin’s disease. Blood 1995; 86: 1694–1700.PubMedGoogle Scholar
  4. 4.
    Nadali G, Vinante F, Stein H et al. Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large-cell lymphoma. J Clin Oncol 1995; 13: 1355–60.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London 1999

Authors and Affiliations

  • H. Stein

There are no affiliations available

Personalised recommendations